We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRR
426
DELISTED
Carbo Ceramics Inc.
CRR
| $2.24M | 0.01% |
19,233
-191,972
| -91% | -$21.8M |
|
427
Cullen/Frost Bankers
CFR
$10.3B
| $2.19M | 0.01% |
29,365
+777
| +3% | +$55.6K |
|
428
Baxter International
BAX
$11.6B
| $2.19M | 0.01% |
57,815
+1,501
| +3% | +$54.4K |
|
429
Brookfield
BN
$102B
| $2.17M | 0.01% |
239,034
+41,539
| +21% | +$378K |
|
430
Sherwin-Williams
SHW
$78.3B
| $2.17M | 0.01% |
35,469
| – | – |
|
431
Neogen
NEOG
$2.05B
| $2.15M | 0.01% |
125,691
-1
| -0% | -$17 |
|
|
STR
432
DELISTED
QUESTAR CORP
STR
| $2.15M | 0.01% |
93,692
+1,850
| +2% | +$42.5K |
|
433
Shore Bancshares
SHBI
$790M
| $2.15M | 0.01% |
233,239
| – | – |
|
434
Goldman Sachs
GS
$313B
| $2.11M | 0.01% |
11,882
+352
| +3% | +$58.1K |
|
|
435
Deckers Outdoor
DECK
$13.3B
| $2.09M | 0.01% |
148,686
-2,239,434
| -94% | -$27.6M |
|
|
ARG
436
DELISTED
Airgas Inc
ARG
| $2.08M | 0.01% |
18,625
| – | – |
|
437
Duke Energy
DUK
$102B
| $2.07M | 0.01% |
30,028
-577
| -2% | -$40.4K |
|
438
Range Resources
RRC
$9.11B
| $2.07M | 0.01% |
24,596
+19,100
| +348% | +$1.49M |
|
439
ServiceNow
NOW
$102B
| $2.06M | 0.01% |
183,815
-17,920
| -9% | -$189K |
|
440
Ares Capital
ARCC
$13.5B
| $2.04M | 0.01% |
114,705
+13,417
| +13% | +$236K |
|
441
APA Corp
APA
$12.8B
| $2.03M | 0.01% |
23,619
-1,325
| -5% | -$118K |
|
442
Williams Companies
WMB
$90.5B
| $2.01M | 0.01% |
52,181
+3,650
| +8% | +$131K |
|
|
SIAL
443
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $2M | 0.01% |
21,293
+3,285
| +18% | +$285K |
|
|
DTV
444
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.96M | 0.01% |
28,355
+9,982
| +54% | +$639K |
|
|
PXD
445
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.94M | 0.01% |
10,535
-736
| -7% | -$142K |
|
446
Parker-Hannifin
PH
$125B
| $1.94M | 0.01% |
15,065
+2,295
| +18% | +$267K |
|
|
ABGB
447
DELISTED
Abengoa SA Class B
ABGB
| $1.92M | 0.01% |
+127,454
| New | +$1.62M |
|
448
J.M. Smucker
SJM
$12.6B
| $1.92M | 0.01% |
18,499
+279
| +2% | +$29.6K |
|
449
FedEx
FDX
$74.5B
| $1.91M | 0.01% |
13,284
-873
| -6% | -$116K |
|
|
KMI.WS
450
DELISTED
Kinder Morgan Inc
KMI.WS
| $1.9M | 0.01% |
467,684
-50,000
| -10% | -$216K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.